SBI Group

Activity from announced rounds

Activity in this selectionSeries C+
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$168M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

Biotech1
Fintech1

By country

United States2

Rounds

2 in this selection
Fasset

AI-powered stablecoin neobanking platform enabling cross-border financial access

$68MSeries C
Role not disclosed
Rakuten Medical

Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment

$100MSeries F
Role not disclosed